FILED DECEMBER 22, 2020 In the Office of the Clerk of Court WA State Court of Appeals, Division III
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON DIVISION THREE
STATE OF WASHINGTON, ) No. 37140-9-III ) Respondent, ) ) v. ) UNPUBLISHED OPINION ) RYAN LEWIS FARR, ) ) Appellant. )
LAWRENCE-BERREY, J. — Ryan Farr, committed to Eastern State Hospital after
pleading not guilty by reason of insanity, appeals the trial court’s order authorizing the
hospital to test him for drugs. The order, based on inadmissible hearsay, does not specify
what type of drug tests are authorized or under what circumstances any particular test may
be administered. We reverse and remand so the trial court may consider admissible
evidence and remedy the scope of its order.
FACTS
In 2012, the State charged Ryan Lewis Farr with two counts of first degree assault,
one count of first degree robbery, and one count of first degree arson. After undergoing
competency evaluations, Farr moved for a judgment of acquittal by reason of insanity
pursuant to RCW 10.77.080. The trial court accepted Farr’s not guilty by reason of
insanity plea and ordered him committed to Eastern State Hospital (ESH). No. 37140-9-III State v. Farr
Pursuant to RCW 10.77.140, ESH submitted reports on Farr’s treatment and
progress every six months. The trial court received 11 reports detailing Farr’s behavioral
and substance abuse treatment.1 Early in his commitment, Farr was caught ingesting
alcohol-based hand sanitizer. He requested benzodiazepines from his psychiatrist despite
being repeatedly denied due to his drug history. In July 2016, staff observed a powdery
substance that Farr attempted to hide from view. Staff suspected it was crushed
medication but could not obtain a large enough sample to test. In August 2016, Farr was
caught with another patient’s medication, which he swallowed before it could be
confiscated. In September 2016, staff and patients reported Farr tried to obtain other
patients’ medications. In October 2016, Farr was caught with a substance thought to be
hash oil. Shortly thereafter, staff found Farr with a white substance later identified as
Wellbutrin, likely taken from another patient.
On December 20, 2017, Farr and another patient used cannabis. ESH staff
reported Farr “‘appeared intoxicated’” and was “‘observed to be high.’” Sealed Clerk’s
Papers (SCP) at 236. Farr denied using and refused multiple urinalysis (UA) requests. In
October 2018, Farr submitted an altered urine sample that was cool to the touch and light
in color. Upon request, he provided another sample that tested positive for
1 The trial court had 10 reports in Farr’s file when it issued the challenged order.
2 No. 37140-9-III State v. Farr
methamphetamine. When Farr’s treatment team confronted him about his use, he
reverted to self-injurious behavior and “‘proceeded to bang his head against the treatment
room wall several times resulting in a need to be contained.’” SCP at 240. Following
this incident, Farr began refusing UA requests, stating, “‘it is my right to refuse the UA’s,
I am taking a stand.’” SCP at 242.
In February 2019, Farr displayed “suspicious behavior in the patient dining room,”
and later was seen “concealing an item (wrapped in folded white paper) within his
undergarments and when confronted by staff he rushed to the men’s restroom (while a
peer blocked staff’s entry) and was observed splashing copious amounts of water and
liquid soap on and around his mouth and face.” SCP at 248. Farr denied anything strange
happened but refused a UA. In March 2019, Farr’s UA showed the presence of alcohol.
His treatment team stated, “This was of great concern given Mr. Farr’s history of
ingesting (for intoxicating purposes) alcohol-based hand sanitizer and the deleterious
effect this would have on his already compromised liver.” SCP at 249. Farr resumed
compliance with UAs until early August 2019. The May 1, 2019 report stated: “Since
3/13/19, Mr. Farr appears to be making more prudent choices; he has complied with twice
weekly urine drug screens and cooperated with room searches,” but after describing the
obstacles Farr faced concluded, “Mr. Farr remains in need of continued risk mitigation
3 No. 37140-9-III State v. Farr
and management given the fragility of his mental illness combined with his polysubstance
use dependence disorder.” SCP at 252.
The progress reports repeatedly emphasize the importance of drug screening for
Farr’s health and wellbeing given his history of drug abuse and cirrhotic liver. Regularly
scheduled drug tests promote accountability and sustained success in Farr’s treatment.
Farr admits he does better when watched, but insists it is his “‘right’” not to take UAs.
SCP at 242 (emphasis omitted). Farr’s treatment team requested a court order mandating
drug screening in the event Farr refuses UAs and other testing methods in the future.
In September 2019, the State moved for an order permitting ESH to conduct drug
testing of Farr “including urinalysis, nail sample testing, and hair sample testing.”
Clerk’s Papers (CP) at 145. The motion was based on “the files and records herein, the
declaration of counsel, RCW 10.77.094 and RCW 71.05.217.” CP at 145. The
prosecutor’s declaration read, in relevant part:
Dr. Gregory J. Bahder, Psychiatrist, and Chris B. Phillips, MSW and Psychiatric Social Worker, Eastern State Hospital, have contacted me. They indicated that Mr. Farr was observed on August 12, 2019 appearing heavily sedated, slurring his speech and showing difficulty in ambulating, and was observed staggering about the ward. He subsequently tested positive for a type of benzodiazepine that he is not prescribed. He has since refused drug screens as well [as] refused less intrusive methods such as hair or fingernail samples. He does say that it is normal for him to periodically use drugs even in a secure environment and that this should not be held against his progress. He freely expresses that he is not able to maintain
4 No. 37140-9-III State v. Farr
sobriety of his own accord. He has been in possession of marijuana and marijuana products . . . . He has tested positive for methamphetamine. He has a history of storing “clean” urine in his room and using this when asked to test. Of primary concern for his treatment team and the hospital is this individual’s health and well-being, particularly related to his compromised liver.
CP at 146. Declarations from Dr. Bahder and Mr. Phillips were not attached to the
motion.2 The court appointed counsel for Farr.
In October 2019, the court held a hearing on the State’s motion. The State called
no witnesses and provided no evidence beyond that included in the court’s file, including
its declaration.
Counsel for Farr objected to the order, and argued:
The State is relying on [RCW] 10.77.094, which has nothing to do with [its motion today]. There is no specific authorization. Therefore, this must fall [sic].
Free access — add to your briefcase to read the full text and ask questions with AI
FILED DECEMBER 22, 2020 In the Office of the Clerk of Court WA State Court of Appeals, Division III
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON DIVISION THREE
STATE OF WASHINGTON, ) No. 37140-9-III ) Respondent, ) ) v. ) UNPUBLISHED OPINION ) RYAN LEWIS FARR, ) ) Appellant. )
LAWRENCE-BERREY, J. — Ryan Farr, committed to Eastern State Hospital after
pleading not guilty by reason of insanity, appeals the trial court’s order authorizing the
hospital to test him for drugs. The order, based on inadmissible hearsay, does not specify
what type of drug tests are authorized or under what circumstances any particular test may
be administered. We reverse and remand so the trial court may consider admissible
evidence and remedy the scope of its order.
FACTS
In 2012, the State charged Ryan Lewis Farr with two counts of first degree assault,
one count of first degree robbery, and one count of first degree arson. After undergoing
competency evaluations, Farr moved for a judgment of acquittal by reason of insanity
pursuant to RCW 10.77.080. The trial court accepted Farr’s not guilty by reason of
insanity plea and ordered him committed to Eastern State Hospital (ESH). No. 37140-9-III State v. Farr
Pursuant to RCW 10.77.140, ESH submitted reports on Farr’s treatment and
progress every six months. The trial court received 11 reports detailing Farr’s behavioral
and substance abuse treatment.1 Early in his commitment, Farr was caught ingesting
alcohol-based hand sanitizer. He requested benzodiazepines from his psychiatrist despite
being repeatedly denied due to his drug history. In July 2016, staff observed a powdery
substance that Farr attempted to hide from view. Staff suspected it was crushed
medication but could not obtain a large enough sample to test. In August 2016, Farr was
caught with another patient’s medication, which he swallowed before it could be
confiscated. In September 2016, staff and patients reported Farr tried to obtain other
patients’ medications. In October 2016, Farr was caught with a substance thought to be
hash oil. Shortly thereafter, staff found Farr with a white substance later identified as
Wellbutrin, likely taken from another patient.
On December 20, 2017, Farr and another patient used cannabis. ESH staff
reported Farr “‘appeared intoxicated’” and was “‘observed to be high.’” Sealed Clerk’s
Papers (SCP) at 236. Farr denied using and refused multiple urinalysis (UA) requests. In
October 2018, Farr submitted an altered urine sample that was cool to the touch and light
in color. Upon request, he provided another sample that tested positive for
1 The trial court had 10 reports in Farr’s file when it issued the challenged order.
2 No. 37140-9-III State v. Farr
methamphetamine. When Farr’s treatment team confronted him about his use, he
reverted to self-injurious behavior and “‘proceeded to bang his head against the treatment
room wall several times resulting in a need to be contained.’” SCP at 240. Following
this incident, Farr began refusing UA requests, stating, “‘it is my right to refuse the UA’s,
I am taking a stand.’” SCP at 242.
In February 2019, Farr displayed “suspicious behavior in the patient dining room,”
and later was seen “concealing an item (wrapped in folded white paper) within his
undergarments and when confronted by staff he rushed to the men’s restroom (while a
peer blocked staff’s entry) and was observed splashing copious amounts of water and
liquid soap on and around his mouth and face.” SCP at 248. Farr denied anything strange
happened but refused a UA. In March 2019, Farr’s UA showed the presence of alcohol.
His treatment team stated, “This was of great concern given Mr. Farr’s history of
ingesting (for intoxicating purposes) alcohol-based hand sanitizer and the deleterious
effect this would have on his already compromised liver.” SCP at 249. Farr resumed
compliance with UAs until early August 2019. The May 1, 2019 report stated: “Since
3/13/19, Mr. Farr appears to be making more prudent choices; he has complied with twice
weekly urine drug screens and cooperated with room searches,” but after describing the
obstacles Farr faced concluded, “Mr. Farr remains in need of continued risk mitigation
3 No. 37140-9-III State v. Farr
and management given the fragility of his mental illness combined with his polysubstance
use dependence disorder.” SCP at 252.
The progress reports repeatedly emphasize the importance of drug screening for
Farr’s health and wellbeing given his history of drug abuse and cirrhotic liver. Regularly
scheduled drug tests promote accountability and sustained success in Farr’s treatment.
Farr admits he does better when watched, but insists it is his “‘right’” not to take UAs.
SCP at 242 (emphasis omitted). Farr’s treatment team requested a court order mandating
drug screening in the event Farr refuses UAs and other testing methods in the future.
In September 2019, the State moved for an order permitting ESH to conduct drug
testing of Farr “including urinalysis, nail sample testing, and hair sample testing.”
Clerk’s Papers (CP) at 145. The motion was based on “the files and records herein, the
declaration of counsel, RCW 10.77.094 and RCW 71.05.217.” CP at 145. The
prosecutor’s declaration read, in relevant part:
Dr. Gregory J. Bahder, Psychiatrist, and Chris B. Phillips, MSW and Psychiatric Social Worker, Eastern State Hospital, have contacted me. They indicated that Mr. Farr was observed on August 12, 2019 appearing heavily sedated, slurring his speech and showing difficulty in ambulating, and was observed staggering about the ward. He subsequently tested positive for a type of benzodiazepine that he is not prescribed. He has since refused drug screens as well [as] refused less intrusive methods such as hair or fingernail samples. He does say that it is normal for him to periodically use drugs even in a secure environment and that this should not be held against his progress. He freely expresses that he is not able to maintain
4 No. 37140-9-III State v. Farr
sobriety of his own accord. He has been in possession of marijuana and marijuana products . . . . He has tested positive for methamphetamine. He has a history of storing “clean” urine in his room and using this when asked to test. Of primary concern for his treatment team and the hospital is this individual’s health and well-being, particularly related to his compromised liver.
CP at 146. Declarations from Dr. Bahder and Mr. Phillips were not attached to the
motion.2 The court appointed counsel for Farr.
In October 2019, the court held a hearing on the State’s motion. The State called
no witnesses and provided no evidence beyond that included in the court’s file, including
its declaration.
Counsel for Farr objected to the order, and argued:
The State is relying on [RCW] 10.77.094, which has nothing to do with [its motion today]. There is no specific authorization. Therefore, this must fall [sic]. [Farr’s] right to due process under the 4th Amendment, his right under Article 1, Section 7 are being asked to be curtailed. . . . [T]his is a significant fundamental right. The nature of this hearing does not comport with the formality required with regard to any sort of constitutional right being abridged. .... We do need to have testimony . . . . It is a fundamental right to his liberty. . . . The State is asking to be able to hold him down and pull hair out of his head.
2 Farr correctly notes that some of the information relayed in the prosecutor’s statement was not in the court file when the court ruled. Some of the information is in Farr’s November 1, 2019 progress report.
5 No. 37140-9-III State v. Farr
I don’t think this is something that we should take lightly with a two page affidavit that’s comprised solely of hearsay.
Report of Proceedings (RP) (Oct. 14, 2019) at 7-8.
The court granted the order authorizing ESH to conduct drug testing of the
defendant, “including urinalysis, nail sample testing, and hair sample testing.” CP at 158
(emphasis added). The written order included the following findings:
1. The defendant was found not guilty of [sic] reason of insanity of Assault in the First Degree and committed to Eastern State Hospital on November 1, 2013. 2. The defendant has tested positive for controlled substances that are not normally prescribed for patients at Eastern State Hospital, including but not limited to certain benzodiazepines, methamphetamine, and marijuana. 3. The defendant has since refused drug screens as well [as] refused less intrusive methods such as hair or fingernail samples. 4. The defendant’s fragile liver and overall hepatic health continue to be in danger without the ability to perform drug screens.
CP at 157-58.
Farr timely appealed the order.
ANALYSIS
Farr raises three arguments. We separate his first argument into two subparts:
(1) the order must be reversed because (a) there is no statutory authority supporting it and
(b) its findings of fact are based on hearsay; (2) because of the important privacy interests
at stake here, due process requires a hearing with live witnesses subject to cross-
6 No. 37140-9-III State v. Farr
examination; and (3) the order violates Farr’s privacy rights under the state and federal
constitutions.
STATUTORY AUTHORITY
Farr argues there is no statutory authority for state hospitals to involuntarily drug
test persons acquitted by reason of insanity. The State responds that both RCW 10.77.094
and RCW 10.77.210 support the trial court’s order. We partly agree with the State.
We review issues of statutory construction de novo. State v. Dennis, 191 Wn.2d
169, 172, 421 P.3d 944 (2018). When engaging in statutory interpretation, our primary
goal is to effectuate legislative intent. Id. We derive legislative intent from the plain
language of the provision, its context within the statute, and the statutory scheme as a
whole. State v. Evans, 177 Wn.2d 186, 192, 298 P.3d 724 (2013).
RCW 10.77.094 provides in relevant part: “A state hospital may administer
antipsychotic medication without consent to an individual who is committed under this
chapter as criminally insane” following procedures outlined in chapter 71 RCW. This
statute does not authorize involuntary drug testing of committed persons.
RCW 10.77.210 provides in relevant part: “Any person involuntarily detained,
hospitalized, or committed pursuant to the provisions of this chapter shall have the right
to adequate care and individualized treatment.” Especially here, where Farr’s weak liver
7 No. 37140-9-III State v. Farr
could be further damaged by toxic substances, adequate care and individualized treatment
includes preventing substance abuse. Monitoring for substance abuse is an integral part
of preventing it. We conclude that RCW 10.77.210 authorizes a trial court to order drug
testing if adequate care and individualized treatment so warrant.
HEARSAY
Farr contends the trial court’s order authorizing drug testing was based on hearsay.
He argues findings of fact 2, 3, and 4 were based on hearsay in the prosecutor’s
declaration and the remaining unchallenged finding does not support the trial court’s
order. We agree.
CR 7(b) governs motions in criminal cases. CrR 8.2. CR 7(b) permits a party to
apply to a court for an order, commonly referred to as a motion. A party filing a motion
has the burden of presenting sufficient facts to warrant the court’s exercise of discretion
in the party’s favor. State v. Aldana Graciano, 176 Wn.2d 531, 539, 295 P.3d 219
(2013). Facts supporting a motion must be presented by a sworn affidavit or an unsworn
written statement (declaration, verification, or certificate) in a form prescribed by statute.
RCW 9A.72.085. If a party properly objects to inadmissible evidence, a court must not
consider it.
8 No. 37140-9-III State v. Farr
In general, hearsay is not admissible. ER 802. “‘Hearsay’ is a statement, other
than one made by the declarant while testifying at the trial or hearing, offered in evidence
to prove the truth of the matter asserted.” ER 801(c). ESH’s reports in the court file are
hearsay, as is the prosecutor’s declaration of what two individuals said.
ER 1101(c) permits a court to consider hearsay evidence in various situations. The
State does not assert, nor do we believe, that any provision of this rule applies here. We
conclude that the order is not supported by admissible evidence. We, therefore, reverse
and remand so the State may present admissible evidence to support its motion, such as
two declarations and attachments.
PROCEDURAL DUE PROCESS
Farr contends his right to procedural due process was denied because the trial court
did not permit him to call or cross-examine witnesses. Because this issue will present
itself on remand, we address Farr’s argument.
“The fundamental requirement of due process is the opportunity to be heard ‘at a
meaningful time and in a meaningful manner.’” Mathews v. Eldridge, 424 U.S. 319, 333,
96 S. Ct. 893, 47 L. Ed. 2d 18 (1976) (quoting Armstrong v. Manzo, 380 U.S. 545, 552,
85 S. Ct. 1187, 14 L. Ed. 2d 62 (1965)). When analyzing due process claims, we consider
three factors:
9 No. 37140-9-III State v. Farr
First, the private interest that will be affected by the official action; second, the risk of an erroneous deprivation of such interest through the procedures used, and the probable value, if any, of additional or substitute procedural safeguards; and finally, the Government’s interest, including the function involved and the fiscal and administrative burdens that the additional or substitute procedural requirement would entail.
Id. at 335.
The first Mathews factor directs us to consider the private interest affected. Here,
the private interest depends on the intrusiveness of the particular type of drug test ESH
wishes to administer. For instance, Farr’s privacy interest is minimally affected by a
nonintrusive urinalysis or a nail sample, it is moderately affected by a blood draw, and it
is significantly affected by use of a catheter to obtain a urine sample.
The second Mathews factor requires us to consider the risk of an erroneous
decision and the probable value of Farr’s proposed additional procedures. The facts the
trial judge will rely on will be supplied by professionals who are charged with ensuring
Farr’s health and recovery. We doubt they have any motive to fabricate or embellish.
Cross-examination is unlikely to uncover a mistake or any deceit in the facts or opinions
they present to the court. Nevertheless, permitting Farr to question one or both
witnesses—either by deposition or in court—might assist the court in crafting a narrower,
yet workable, order. Alternatively, Farr can present a declaration from his own expert to
10 No. 37140-9-III State v. Farr
assist the court. Farr’s ability to cross-examine one or both witnesses may be useful, but
it is not necessary.
Finally, the third Mathews factor directs us to consider the State’s interest and the
fiscal and administrative burdens additional procedures would entail. ESH has a statutory
duty to provide adequate care and individualized treatment for all committed persons
under its care. RCW 10.77.210. Requiring multiple professionals to appear in court,
perhaps 200 miles away, to obtain an order permitting drug testing would both burden
ESH and might jeopardize the care of others under its care.
Weighing the three Mathews factors, we conclude that Farr’s right to procedural
due process would not be violated by a nontestimonial hearing, unless the State sought to
use a highly intrusive drug test. Nevertheless, the trial court might consider permitting
Farr to depose one or both witnesses if doing so would assist the court in crafting an
appropriate order.
PRIVACY RIGHTS
Farr and amici curiae3 argue that the trial court’s overly broad order violates Farr’s
privacy rights under article I, section 7 of the Washington Constitution. Farr asserts that
3 Disability Rights Washington and the American Civil Liberties Union of Washington Foundation.
11 No. 37140-9-III State v. Farr
his status as an acquittee provides him greater privacy rights against drug testing than the
convicted probationer in State v. Olsen, 189 Wn.2d 118, 399 P .3d 1141 (2017). Amici
curiae assert that the order erroneously permits ESH to drug test Farr without reasonable
suspicion and to obtain a urine sample by forced catheterization.
We do not reach these arguments because we have reversed the order on other
grounds and any discussion of these issues would be an improper advisory opinion.
Walker v. Munro, 124 Wn.2d 402, 411-12, 879 P.2d 920 (1994). We are confident the
trial court can issue a narrowly tailored order that authorizes ESH to administer specific
and appropriate drug tests under appropriate circumstances consistent with its duty to
provide Farr adequate care and individualized treatment.
A majority of the panel has determined this opinion will not be printed in the
Washington Appellate Reports, but it will be filed for public record pursuant to
RCW 2.06.040.
Lawrence-Berrey, J. r WE CONCUR: j'
Fearing, J.